Ningxia Zhongke Biotechnology Co., Ltd. Class A

Ningxia Zhongke Biotechnology Co., Ltd. Class A

SSSE:600165
2.46
CNY
-0.07
(-2.77%)
-0.05EPS
5.41BMarket Cap
Ningxia Zhongke Biotechnology Co., Ltd. Class A
SSE:600165
(Shanghai Stock Exchange)

Recent

price

2.46

P/E

ratio

- -

div

yld

0.26%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
3.34
2.72
2.68
2.6
4.9
1.57
4.06
1.83
0.82
0.39
0.18
0.36
0.88
0.42
0.5
0.28
0.33
Revenue per Share
-0.11
- -
0.06
0.01
-0.39
0.07
-0.28
0.06
0.01
-0.07
0.03
-0.24
-0.31
-0.68
-0.79
-0.06
-0.02
Basic EPS, GAAP
-0.44
-0.41
-0.25
-0.08
-0.97
-0.39
-0.29
0.13
-0.38
-0.8
-1.15
-0.38
-0.14
-0.05
-0.13
-0.4
- -
Free Cash Flow per Basic Share
0.1
0.08
0.07
0.08
0.19
0.08
0.11
0.05
0.03
0.07
0.07
0.08
0.08
0.03
0.01
- -
0.01
Dividend per Share
0.89
1.44
1.5
1.5
1.34
1.41
1.16
1.26
1.26
1.3
1.4
1.12
0.82
0.14
0.1
0.75
0.63
Book Value per Share
0.76
1.34
1.43
1.39
1.25
-0.87
0.2
1.25
1.19
1.23
1.32
1.05
0.7
0.04
0.01
0.71
0.59
Tangible Book Value per Share
484
616
687
680
274
688
686
683
671
681
674
683
685
684
685
1,614
1,614
Basic Weighted Avg Shares
1,618
1,677
1,842
1,764
1,343
1,077
2,785
1,248
552
266
119
249
605
286
345
444
528
Sales/Revenue/Turnover
-1.9
2.24
2.55
2.25
-6.51
-3.65
-3.11
-0.78
-0.38
-15.42
-12.62
-56.87
-21.63
-58.38
-42.73
-45.45
-26.6
Operating Margin (%)
53
49
55
74
75
66
72
41
14
15
15
60
123
138
127
128
- -
Depreciation Expense
-54
2
42
8
-108
46
-192
38
9
-45
21
-166
-211
-465
-539
-90
-30
Net Income, GAAP
- -
37.86
8.01
37.33
- -
3.07
- -
2.82
3.12
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-3.33
0.12
2.3
0.43
-8.04
4.28
-6.89
3.06
1.7
-16.91
17.55
-66.78
-34.9
-162.66
-156.06
-20.33
-5.76
Profit Margin (%)
-66
420
408
146
-304
-484
-15
261
43
82
-423
-768
-1,392
-1,682
-1,683
506
268
Working Capital
184
155
135
115
30
1,113
800
- -
- -
30
362
491
283
215
1
1
2
LT Debt
494
1,046
1,088
1,034
924
1,031
903
1,020
989
918
1,273
1,064
817
306
240
1,336
1,144
Total Equity
- -
-0.17
1.73
-0.82
- -
0.48
- -
0.59
0.64
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
1.48
4.77
2.21
- -
4.8
- -
5.53
2.32
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-11.67
0.28
4.21
0.74
-11.07
4.89
-21.82
4.61
1.09
-5.12
2.26
-19.24
-31.72
-141.04
-630.48
-14.12
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
10
13
15
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
1
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,616
1,616
1,616
Market Capitalization
5,413
4,088
5,413

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
712
612
547
Cash, Cash Equivalents & STI
272
190
96
Accounts Receivable, Net
115
119
119
Inventories
173
178
195
Total Current Liabilities
263
262
279
Payables & Accruals
- -
- -
- -
ST Debt
10
13
15
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
36.16%
66.53%
456.29%
Free Cash Flow
17.6%
115.29%
605.26%
Net Income, GAAP
-225.11%
-162.88%
-83.23%
Sales/Revenue/Turnover
18.94%
49.74%
28.72%
Total Cash Common Dividend
-10.64%
-35.97%
-53.68%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
54
60
71
161
345
2025
94
122
- -
117
444
2026
118
157
136
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.07
-0.55
-0.08
-0.09
-0.79
2025
-0.09
-0.16
- -
0.1
-0.06
2026
-0.04
-0.04
-0.04
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) manufactures and sells chemical raw materials and products, primarily coal-based activated carbon and long-chain dibasic acids including lauric acid. The company produces water purification activated carbon, air purification carbon, solvent recovery carbon, catalyst carrier carbon, chemical protective carbon, mercury removal carbon, and lauric acid for applications in environmental protection, catalysis, and chemical synthesis; it operates through subsidiaries such as Ningxia Zhongke Biotech New Materials Co., Ltd., Ningxia Xinri Hengli International Trade Co., Ltd., and Ningxia Huahui Environmental Technology Co., Ltd. Founded in 1958 and listed on the Shanghai Stock Exchange in 1998, the company, formerly Ningxia Xinri Hengli Steel Wire Co., Ltd., is headquartered in Yinchuan, Ningxia, China, with principal operations in the domestic market and overseas exports. Recent business developments include a strategic shift from steel wire production to biotechnology and chemicals, ongoing optimization of asset structure through mergers, acquisitions, and restructuring, and sustained focus on bio-based and starch-based new materials alongside coal processing. The company employs 834 people and generated trailing twelve-month revenue of CNY447.41 million as of the latest reported period.